Summary slide.png (137.49 kB)

The Future of Respiratory Syncytial Virus Disease Prevention and Treatment

Version 2 2021-01-07, 12:29

Version 1 2020-12-24, 09:59

figure

posted on 2021-01-07, 12:29 authored by Joseph B. Domachowske, Evan J. Anderson, Mitchell Goldstein

Article full text

There are currently no digital features for this article. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).

History

Usage metrics

Keywords

American Academy of Pediatrics High-risk preterm infants Immunoprophylaxis Monoclonal antibody National Perinatal Association Palivizumab Respiratory syncytial virus Treatment Vaccine

Licence

CC BY-NC 4.0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM